Enzalutamide (Xytiga)

Enzalutamide is a next generation anti-androgen. This medication works by blocking the androgen receptor, the protein responsible for causing prostate cancer progression. Enzalutamide is FDA approved for the treatment of men with metastatic hormone refractory prostate cancer.